ADHD in the News 2015-10-20
Weak Brain Connections May Link Premature Birth And Later Disorders
There's evidence that preemies are born with weak connections in some critical brain networks, including those involved in focus, social interactions, and emotional processing, researchers reported at the Society for Neuroscience meeting in Chicago.
Researchers say medication, parent coaching can reduce ADHD in children with autism
Researchers say a drug called atomoxetine, when paired with parent coaching, can significantly reduce the manifestations of attention deficit hyperactivity disorder (ADHD) in children with autism.
Altitude is a Protective Factor for ADHD Diagnosis
Rates of attention deficit hyperactivity disorder (ADHD) drop as elevation increases, according to findings published in the Journal of Attention Disorders.
Guanfacine extended-release efficacious, well-tolerated for adolescent ADHD
Results from a 13-week, multicenter, randomized, double blind, placebo-controlled trial indicate guanfacine extended-release was associated with significant improvement in attention deficit/hyperactivity disorder symptoms in adolescents.
Announcing the First Innovative Program That Takes Drivers Education to the Next Level
Behind the Wheel With ADHD provides driving instructors with additional training to understand the risks associated with ADHD and teen driving. Instructors are trained in the use of new tools, technologies, and strategies designed to help teens with ADHD learn to drive more safely.
Brain training can help with anxiety and ADHD
Brain training, or neurofeedback, has been around for a long time. Now, new technology and research on its effectiveness have created new interest in the field. Patients are using neurofeedback instead of medications to help with a variety of conditions from migraines and stress to severe anxiety.
Adult ADHD: A Review of the Clinical Presentation, Challenges, and Treatment Options
This continuing medical education activity is intended for psychiatrists, psychologists, primary care physicians, physician assistants, nurse practitioners, and other health care professionals who seek to improve their care for patients with mental health disorders.
Ugonjwa wa ADHD unaoweza kuathiri utotoni unaoweza kuathiri utotoni unaoweza kuathiri utotoni unaoweza kuathiri utotoni unaoweza kuathiri utotoni unaoweza kuathiri utotoni unaoweza kuathiri utotoni unaoweza kuathiri utotoni unaoweza kuathiri utotoni unaoweza kuathiri utotoni unaoweza kuathiri utotoni. Utafiti wa utafiti unaonyesha kwamba dawa za kulevya zinaweza kupunguza ADHD kwa watoto wenye autism, na dawa ya atomoxetine, ikiwa imeunganishwa na mafunzo ya wazazi, inaweza kupunguza dalili za ADHD kwa watoto wenye autism. "Uwezo wa kupima kiwango cha ADHD (attention deficit hyperactivity disorder) hupungua kwa sababu ya kuongezeka kwa urefu wa ardhi, kulingana na utafiti uliochapishwa katika jarida la ""Journal of Attention Disorders.""" Guanfacine Extended Release Effective, Well-Tolerated for Adolescent ADHD Matokeo ya wiki 13, multicenter, randomized, double-blind, placebo-controlled trial, yanaonyesha guanfacine extended-release ilikuwa na uhusiano na uboreshaji mkubwa katika dalili za ADHD katika vijana. Programu ya kwanza ya Uvumbuzi ambayo Inachukua Elimu ya Madereva kwa Ngazi ya Baadaye nyuma ya Gurudumu na ADHD hutoa walimu wa kuendesha gari mafunzo ya ziada ili kuelewa hatari zinazohusiana na ADHD na kuendesha gari kwa vijana. Mwalimu wa gari hufundishwa kutumia vifaa vipya, teknolojia, na mbinu zilizobuniwa ili kuwasaidia matineja wenye ADHD kujifunza kuendesha gari kwa usalama zaidi. Mafunzo ya ubongo yanaweza kusaidia na wasiwasi na ADHD Mafunzo ya ubongo, au neurofeedback, yamekuwa karibu kwa muda mrefu. Sasa, teknolojia mpya na utafiti kuhusu ufanisi wake umechochea upendezi mpya katika uwanja huo. Kwa sasa, watu wengi wanatumia neurofeedback badala ya dawa kusaidia na hali mbalimbali kutoka migraines na mkazo kwa wasiwasi mkubwa. ADHD: Mapitio ya Uwasilishaji wa Kliniki, Changamoto, na Chaguzi za Matibabu: Shughuli hii ya kuendelea ya elimu ya matibabu inakusudiwa kwa wagonjwa wa akili, wanasaikolojia, madaktari wa huduma ya msingi, wasaidizi wa daktari, wauguzi, na wataalamu wengine wa huduma ya afya ambao wanatafuta kuboresha huduma yao kwa wagonjwa wenye matatizo ya afya ya akili.